14180-05-3Relevant academic research and scientific papers
Method of treating or preventing myocardial ischemia-reperfusion injury using NF-kB inhibitors
-
Page/Page column 16-17, (2008/06/13)
The present invention concerns a method of treatment or prevention of myocardial ischemia-reperfusion injury by diagnosing that a person is in need of treatment or prevention of myocardial ischemia-reperfusion injury and administering a therapeutically ef
METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS
-
Page/Page column 38, (2010/02/11)
The present invention concerns a method of treating rheumatoid arthritis by diagnosing that a person is in need of treatment for rheumatoid arthritis and administering a therapeutically effective amount of a ligand which modulates NF-kB transcription fact
METHODS OF TREATING ATHEROSCLEROSIS USING NF-kB INHIBITORS
-
Page/Page column 40, (2008/06/13)
The present invention concerns a method of treating atherosclerosis by diagnosing that a person is in need of treatment for atherosclerosis and administering a therapeutically effective amount of a ligand which modulates NF-kB transcription factor by inte
Methods of treating rheumatoid arthritis using NF-kB inhibitors
-
Page/Page column 17, (2008/06/13)
The present invention concerns a method of treating rheumatoid arthritis by diagnosing that a person is in need of treatment for rheumatoid arthritis and administering a therapeutically effective amount of a ligand which modulates NF-kB transcription fact
Preparation of sulphonated aromatic esters
-
, (2008/06/13)
A process for preparing sulphonated aromatic esters of the group consisting of substituted or unsubstituted sulphonato-phenyl carboxylates and sulphonato-phenyl carbonates is disclosed, comprising the steps of: (1) preparing the unsulphonated aromatic ester; (2) sulphonating said unsulphonated aromatic ester; and (3) neutralizing the acid-sulphonated aromatic ester in a non-aqueous organic solvent with an alkali metal, earth alkali metal or ammonium carboxylate in an amount in excess over the amount needed to neutralize the sulphonic acid group(s) and any free or complexed SO3 present in the product mixture from the sulphonation reaction. Preferred neutralizing agent is sodium acetate; preferred solvents are acetic acid or glyme and diglyme.
